BXP
52
2
PVH
57
5
BWA
46
2
ADSK
68
2
SJM
21
2
EMC
53
5
IPG
53
4
CI
52
7
ETN
79
4
AMG
52
2
FRT
45
6
A
41
5
PAYX
51
4
WEC
55
2
V
66
6
DGX
50
2
DTE
54
4
AIV
70
2
AN
54
4
WHR
64
3
BXP
52
2
PVH
57
5
BWA
46
2
ADSK
68
2
SJM
21
2
EMC
53
5
IPG
53
4
CI
52
7
ETN
79
4
AMG
52
2
FRT
45
6
A
41
5
PAYX
51
4
WEC
55
2
V
66
6
DGX
50
2
DTE
54
4
AIV
70
2
AN
54
4
WHR
64
3
Financhill
Back

Akari Therapeutics PLC Vs. Cellectis SA Industry Stock Comparison

Sell
10

AKTX
Akari Therapeutics PLC

Last Price:
1.25
Seasonality Move:
-8.33%
Buy
57

CLLS
Cellectis SA

Last Price:
1.86
Seasonality Move:
2.21%
Sell
10
Akari Therapeutics PLC (AKTX) is a Sell

Is Akari Therapeutics PLC a Buy, Sell or Hold?

  • The current Akari Therapeutics PLC [AKTX] share price is $1.24. The Score for AKTX is 10, which is 80% below its historic median score of 50, and infers higher risk than normal.
  • AKTX is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
57
Cellectis SA (CLLS) is a Buy

Is Cellectis SA a Buy, Sell or Hold?

  • The current Cellectis SA [CLLS] share price is $1.86. The Score for CLLS is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
  • CLLS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

AKTX Stock Price Chart

What is Akari Therapeutics PLC's stock price today?

  • The Akari Therapeutics PLC share price today is $1.24
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKTX is experiencing slight selling pressure.

CLLS Stock Price Chart

What is Cellectis SA's stock price today?

  • The Cellectis SA share price today is $1.86
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CLLS is experiencing slight buying pressure.

AKTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.28 Sell
Relative Strength Index (14 RSI): 24.41 Sell
Chaikin Money Flow: -35482 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.9 - 2.56) Sell
Bollinger Bands (100): (2.47 - 3.73) Sell

CLLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 46.45 Sell
Chaikin Money Flow: 783 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.79 - 1.93) Buy
Bollinger Bands (100): (1.89 - 2.25) Sell

AKTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.93 Sell
20-day SMA: 2.23 Sell
50-day SMA: 2.61 Sell
200-day SMA: 2.54 Sell
8-day EMA: 1.81 Sell
20-day EMA: 2.13 Sell
50-day EMA: 2.52 Sell
200-day EMA: 2.93 Sell

CLLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.92 Sell
20-day SMA: 1.86 Buy
50-day SMA: 1.99 Sell
200-day SMA: 2.35 Sell
8-day EMA: 1.9 Sell
20-day EMA: 1.89 Sell
50-day EMA: 1.97 Sell
200-day EMA: 2.23 Sell

Akari Therapeutics PLC Earnings Growth & AKTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.60 per share, and a decrease next year of $0.00 per share.

Cellectis SA Earnings Growth & CLLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.79 per share, and a decrease next year of $0.06 per share.

Akari Therapeutics PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Cellectis SA Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):